Toronto Dominion Bank Decreases Holdings in Colgate-Palmolive (NYSE:CL)

Toronto Dominion Bank trimmed its position in shares of Colgate-Palmolive (NYSE:CL) by 3.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 516,848 shares of the company’s stock after selling 20,419 shares during the period. Toronto Dominion Bank owned about 0.06% of Colgate-Palmolive worth $46,542,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Legacy Trust boosted its stake in shares of Colgate-Palmolive by 1.7% in the first quarter. Legacy Trust now owns 6,925 shares of the company’s stock worth $624,000 after acquiring an additional 116 shares during the period. Checchi Capital Advisers LLC boosted its stake in shares of Colgate-Palmolive by 1.5% in the first quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock worth $705,000 after acquiring an additional 118 shares during the period. Regal Investment Advisors LLC boosted its stake in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock worth $604,000 after acquiring an additional 121 shares during the period. M&G Investment Management Ltd. boosted its stake in shares of Colgate-Palmolive by 0.3% in the fourth quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after acquiring an additional 125 shares during the period. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its stake in shares of Colgate-Palmolive by 3.8% in the first quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 3,374 shares of the company’s stock worth $304,000 after acquiring an additional 125 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CL. Evercore ISI increased their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Stifel Nicolaus increased their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday. Argus raised their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. TD Cowen started coverage on shares of Colgate-Palmolive in a research note on Tuesday. They set a “buy” rating and a $110.00 price target on the stock. Finally, Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 10th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.58.

Colgate-Palmolive Trading Up 3.0 %

Shares of Colgate-Palmolive stock traded up $2.91 on Friday, hitting $99.40. 7,137,448 shares of the company traded hands, compared to its average volume of 4,397,363. The stock’s 50 day moving average price is $95.83 and its 200-day moving average price is $90.06. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $100.61. The company has a market cap of $81.55 billion, a PE ratio of 31.46, a PEG ratio of 3.49 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the previous year, the firm posted $0.77 earnings per share. The company’s revenue was up 4.9% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Insider Buying and Selling

In related news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.